Dr. Elizabeth R. Plimack, MD, MS, FASCO (IMAGE)
Caption
Dr. Elizabeth R. Plimack, MD, MS, FASCO, is lead author of a paper in European Urology reporting on an analysis of specimens from the SWOG S1314 trial in localized muscle-invasive bladder cancer that finds that tumors from S1314 patients that had a mutation in any one of three DNA damage-repair genes were much more likely than other tumors to be eliminated by cisplatin-based chemotherapy, a finding that may help in identifying patients who can forego bladder removal surgery in favor of continued surveillance.
Credit
Courtesy of Fox Chase Cancer Center
Usage Restrictions
Credit must be given to the creator. Adaptations must be shared under the same terms.
License
CC BY-SA